Project description
Wearable eye tracking device for Covid-19 patients
The spread of the deadly Covid-19 pandemic across the globe has put a worrying strain on critical care resources. The spike seen in some countries in the number of patients requiring admission to intensive care units necessitates constant communication between doctors and patients and their families. The EU-funded Eyecontrol project will develop an immediate and efficient assistive technology: the first wearable and screenless assistive communication device that secures easy and safe communication between patients, medical and care staff and families. The device is based on eye-tracking technology driven by artificial intelligence; it enables communication through eye movements, without requiring calibration or dependence on a screen or computer. The project will develop additional improvements to its technology, to facilitate entry into the medical facility market.
Objective
EyeFree Assisting Communication Ltd. developed the EyeControl, the first wearable, screenless assistive communication device. AI-powered eye-tracking technology enables communication between patients, medical staff and family, using only eye movements, without calibration or dependency on a screen or computer. EyeFree is changing reality, empowering autonomy among the Locked-in community by providing a round-the-clock communication solution that is operated independently by the user.
EyeFree is expanding the scope of the recently finalized SME Phase 2 grant with the aim of developing additional improvements to the EyeControl technology, which will expedite medical facility market entry strategy. Short-term demand in this segment is growing; where an unmet need for communication in the ICU already existed, it has been further exasperated by an influx of ventilation caused by the Coronavirus. There is no solution on the market; and, that places the EyeControl at the forefront, as an immediate and effective assistive technology, facilitating easy and safe communication between patients, medical staff, caregivers, and families and leading to better quality patient care. Once this niche market has been consolidated, we will boost the market entry be known as the global communication platform for both ventilated and Locked-in patients, with two main product lines: EyeControl Home and Facility.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques.
- medical and health scienceshealth sciencesinfectious diseasesRNA virusescoronaviruses
- engineering and technologymedical engineeringwearable medical technology
You need to log in or register to use this function
Programme(s)
Funding Scheme
SME-2 - SME instrument phase 2Coordinator
6618003 Tel Aviv Jaffa
Israel
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.